
zzso is a checkpoint zzso involved in the zzso response to zzso DNA zzso Its potential as a drug target is still zzso but zzso of zzso may increase the efficacy of zzso cancer therapies in a zzso zzso background by eliminating one of the checkpoints or DNA repair pathways contributing to cellular zzso We report here the identification and characterization of a novel zzso zzso zzso zzso X-ray zzso confirmed that zzso bound to zzso in the zzso zzso This compound zzso zzso with an zzso of 3 zzso and shows minimal zzso against a panel of zzso at 1 zzso zzso blocked zzso activity in human tumor cell lines in response to DNA damage, as shown by zzso of zzso zzso at zzso band shift mobility changes, and zzso zzso zzso did not zzso the zzso of a selection of zzso agents in several cell zzso However, this compound significantly zzso the zzso of two structurally distinct zzso zzso Clear induction of the zzso zzso signal was seen with a zzso inhibitor alone, and this zzso was abolished by zzso zzso that the zzso of zzso inhibitor cell killing by zzso was due to zzso of zzso zzso our findings imply that zzso zzso may exert therapeutic activity in combination with zzso zzso 

